Search clinical trials for: Allergic Rhinoconjunctivitis

Total 4249 results

Charite University, Berlin, Germany

Completed

Vitamin D and Grass Pollen Specific Immunotherapy

Allergic Rhinoconjunctivitis

Germany
Anergis

Completed

Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

Birch Pollen Allergy

Sweden, France, Lithuania, Denmark, Latvia, Poland, Switzerland
Anergis

Completed

Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

Allergic Rhinitis | Rhinoconjunctivitis

France, Sweden, Lithuania, Denmark, Latvia, Poland, Switzerland
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

Seasonal Allergic Rhinitis

Canada
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
Aarhus University Hospital
University of Aarhus; ALK-Abelló A/S; Lundbeck Foundation

Completed

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Allergic Rhinoconjunctivitis
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

Asthma | Seasonal Allergic Rhinitis

Canada
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
Allergopharma GmbH & Co. KG

Completed

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Allergic Asthma | Rhinoconjunctivitis

Germany
BioTech Tools S.A.

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Hay Fever

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Grass Pollen Allergy

Germany
BioTech Tools S.A.

Completed

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
BioTech Tools S.A.

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Hay Fever

Belgium
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Allergic Rhinoconjunctivitis

United States
Bitop AG

Completed

Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis

Allergic Rhinoconjunctivitis

Germany
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Allergic Rhinoconjunctivitis

United States
HAL Allergy
Ergomed

Completed

PURETHAL Birch RUSH Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Grass Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
Leti Pharma GmbH

Completed

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma | Sensitization Against Phleum Pratense Pollen | Dose-Finding Study

Germany
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
Allergopharma GmbH & Co. KG

Completed

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Allergic Rhinoconjunctivitis

Sweden
Allergopharma GmbH & Co. KG

Completed

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma (AMETHYST)

Rhinoconjunctivitis

Germany
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
Stallergenes Greer
Quintiles, Inc.; Aptuit

Completed

Study of rBet v1 Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-related Rhinoconjunctivitis

Denmark, Finland, France, Poland, Germany, Lithuania, Russian Federation, Sweden
Stallergenes Greer
Quintiles, Inc.

Completed

Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
Starx Research Center, LLC

Unknown

Ocular Allergy Treatment Practical Impact Trial ((OAT-PIT))

Allergic Conjunctivitis | Rhinoconjunctivitis

United States
HAL Allergy

Completed

SUBLIVAC FIX Phleum Pratense DT/DRF

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany, Poland
HAL Allergy

Completed

PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Belgium, Germany, Austria, Netherlands, Spain
HAL Allergy

Completed

SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Poland, Czech Republic, Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Birch Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

House Dust Mite Allergy

Germany
ALK-Abelló A/S

Completed

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine (GT-19)

Allergic Rhinoconjunctivitis

Germany
Stallergenes Greer
Quintiles, Inc.; Cenduit LLC; Aptuit Inc.; PHT Corporation

Completed

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Hypersensitivity | Allergic Rhinitis | Allergic Conjunctivitis | Seasonal Allergy

Czech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, Lithuania, Poland, Slovakia, Sweden
ALK-Abelló A/S

Completed

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (GT-17)

Allergic Rhinitis | Grass Allergy

Italy
Faes Farma, S.A.

Completed

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Chronic Urticaria | Allergic Rhinoconjunctivitis

Australia, Germany, Sweden
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Perennial Allergic Rhinitis
Faes Farma, S.A.

Completed

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Seasonal Allergic Rhinitis
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
HAL Allergy

Completed

PURETHAL Grasses Rush Study

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany
HAL Allergy

Completed

SUBLIVAC® Birch PROBE Study

Birch Pollen Allergy | Seasonal Rhinitis and/or Rhinoconjunctivitis

Germany
HAL Allergy

Completed

Twin SUBLIVAC® Grasses Clinical Efficacy Study

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Germany, Poland, Belgium, Netherlands
BioTech Tools S.A.

Completed

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
ALK-Abelló A/S

Completed

Tolerability of Grazax in Patients With Hayfever in Real Life Settings (GRAAL)

Allergic Rhinoconjunctivitis

France

Search clinical trials for: Allergic Rhinoconjunctivitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations